This document is the Advisory Committee on Releases to the Environment (ACRE’s) advice to government in considering a request from Oxford Vaccine Group (16/R48/01). The application is for a deliberate release of genetically modified Salmonella Typhi for research and development purposes.
ACRE is satisfied that the trial will not have an adverse effect on human health or the environment.
Follow this news feed: DEFRA